Capital

Oura's IPO Values A Health Ring At $16 Billion

Oura is targeting a US IPO as early as September 2026, aiming to raise up to $3 billion at a valuation above $16 billion, up from $11 billion a year ago.

CapitalBy Servola Tech Desk2026-08-263 min read

AI-assisted, edited by humans. | Editor-in-Chief: Leon Soliman | Editorial standards

The Numbers Behind The Listing

Oura is reportedly targeting a US initial public offering as early as September 2026, seeking to raise up to $3 billion at a valuation above $16 billion. The underwriting syndicate lines up a full bench of Wall Street names: Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen & Co., and Jefferies. The company filed confidentially with the SEC earlier this year, and a meaningful portion of the shares sold are expected to come from existing investors, not just new capital raised.

None of this is finalized. Timing, size, and price remain subject to change through the SEC review process and broader market conditions, and Oura itself has not publicly confirmed the details reported by people familiar with the plans.

From Hardware Sale To Recurring Revenue

The number that matters more than the valuation is the revenue trajectory behind it. Oura brought in $500 million in revenue in 2024 and is projected to climb to roughly $1.5 billion in 2026, a threefold jump in two years. That growth is not just more rings sold, it is a subscription business proving itself: paid memberships are expected to top 5 million this quarter, on top of cumulative ring sales that have now passed 5.5 million units.

That combination, hardware plus a recurring membership fee for the software and health insights layered on top, is the model a wave of consumer health-tech companies have chased without proving it scales past a niche. Oura's IPO filing is effectively a public test of whether that model produces a durable, investable business.

Why This Matters Beyond Consumer Tech

Two groups of European and UK readers have a direct stake here beyond general market-watching curiosity. Employers who have added Oura rings to corporate wellness benefit programs, a trend that has grown across UK and continental European employers over the past two years, are about to see their benefits vendor go through the kind of ownership and governance change an IPO brings, worth flagging to whoever owns that vendor relationship. And investors weighing exposure to the broader 2026 IPO pipeline, which reporting has grouped Oura alongside SpaceX and OpenAI as part of a surging listing calendar, now have a concrete data point on how the market is pricing a proven consumer-subscription hardware business.

Metric	A year ago	Now (Aug 2026)
Valuation	$11 billion (Series E, Sept 2025)	Above $16 billion (IPO target)
Annual revenue	$500 million (2024)	~$1.5 billion projected (2026)
Paid memberships	Not disclosed at this scale	Expected to exceed 5 million this quarter

The growth in that table is what underwriters are pricing, not the ring itself.

What Could Still Change

Every figure here carries the qualifier 'reportedly' for a reason. Confidential SEC filings do not become public offerings on a fixed schedule, and the gap between a targeted valuation and a priced one can be wide, as several 2025 and 2026 tech listings have shown when public-market appetite shifted between filing and pricing day.

What is firmer is the underlying business math: a $500 million-to-$1.5 billion revenue run in two years, on a subscription base north of 5 million payers, is a real growth story independent of what multiple public investors ultimately assign it. The IPO date is the uncertain part. The demand for the product is not.

Frequently asked questions

When is Oura planning to IPO?

Oura is reportedly targeting a US initial public offering as early as September 2026, though the exact timing is not confirmed and remains subject to SEC review and market conditions.

How much is Oura targeting to raise and at what valuation?

Oura is reportedly aiming to raise up to $3 billion at a valuation above $16 billion, with underwriters including Goldman Sachs, Morgan Stanley, JPMorgan Chase, Allen and Co., and Jefferies.

How has Oura's valuation changed over the past year?

Oura was valued at $11 billion in September 2025 after an $875 million Series E round. The reported IPO target valuation of above $16 billion represents roughly a 45 percent increase in about a year.

Is Oura's IPO confirmed?

No. The details come from reporting citing people familiar with the plans, and Oura filed confidentially with the SEC, meaning terms and timing can still change before any public listing is priced.

A smart ring going public for $16 billion sounds like a valuation story, but the real story is upstream of that number: a hardware company built a subscription business on top of a wearable and grew revenue three times over in two years while crossing five million paying members. That is the part worth remembering after the IPO headlines fade, whether or not the listing prices exactly where reported.

OuraIPOWearablesHealth TechCapital MarketsConsumer Tech

Unitree's $9 Billion IPO Proves China Can Fund Robots

Unitree priced Shanghai's STAR Market IPO at a $9 billion valuation, raised $904 million 8,000 times oversubscribed, and debuted up 629 percent - proving China's own capital markets can now fund frontier robotics without a US listing.

5 min read

Capital

Anthropic's IPO Target Doubled in Ten Weeks

Anthropic's confidential S-1 anchored a 965 billion dollar valuation in June. By August 13, reports put the October IPO target at 2 trillion dollars - a figure that moved by over a trillion in ten weeks, before any public prospectus existed.

4 min read

Decisions

The Third Pivot Was the Warning Magic Leap Missed

Magic Leap filed a WARN notice for 193 layoffs effective 1 October 2026, its fourth strategic pivot after $4 billion raised. The lesson is the pattern, not the pivot.